Introduction {#s0005}
============

Since December 2019, a viral pneumonia, COVID-19, broke out in Wuhan and quickly sweeping the world, which arousing widespread concern.[@bb0005] The pathogen of this viral pneumonia is 2019-nCoV which is highly infectious through respiratory droplets and close contact spread, susceptible groups are all groups.[@bb0010] To preventing the spread of COVID-19, people all stayed home, going out as little as possible.

Dermatomyositis(DM) is a rare refractory autoimmune disease characterized by pathognomonic cutaneous manifestations and may or may not parallel myositis combined with other systems involvement.[@bb0015] The patients with dermatomyositis have a high risk of developing interstitial lung disease (ILD)^4^and malignancy. Due to the use of systemic corticosteroids and(or)immunosuppressive agents, DM patients are more susceptible to infection than healthy individuals. Besides, Beydon.et al. has reported a case of COVID-19 which presented as acute myositis.[@bb0025] The latest research also revealed that three immunogenic linear epitopes with high sequence identity to SARS-CoV-2 proteins in patients with autoimmune dermatomyositis, which means latent exposure to 2019-nCoV might conduce to musculoskeletal autoimmune disease development.[@bb0030] Therefore, the patients with DM should be a priority group for COVID-19 prevention.1.Condition assessment

We followed up 52 DM patients who were hospitalized in our hospital from January 2019 to January 2020 by telephone, of which 11 patients were lost to follow-up because the phone number wasn\'t available or the patient refused to answer and 7 patients have died. Among the 7 died patients, none of the patients came down with COVID-19. Two patients died of severe pneumonia and respiratory failure shortly after discharge from our hospital in 2019. Four patients died of nasopharyngeal carcinoma and one patient died of lung carcinoma. None of 34 followed-up patients came down with COVID-19. The results are shown in [Table 1](#t0005){ref-type="table"} and the following problems were found: (i)Although the vast majority of patients didn\'t interrupt their treatment, the therapeutic schedule was not properly guided and adjusted, which led to side effects such as increased liver enzymes and swollen feet. (ii)The patients especially who combined with IDL or malignancy were afraid being infected with pneumonia during the COVID-19 due to their high susceptibility, which caused a great psychological burden to them. (iii) 22 patients chosen to go to the hospital for further consultation despite the risk of infection and 12 patients didn\'t communicate with doctor during the epidemic. There are no one chose telemedicine for further consultation among the follow-up patients.2.Patient management Table 1The followed-up results of 34 patientsTable 1ResultsNumbers of cases (N = 34)Gender\
Female\
Male\
Age (28--66 years)\
28--49 years\
50--66 years\
Complication\
interstitial lung disease\
malignancy\
Continuous therapy\
yes\
no\
[⁎](#tf0005){ref-type="table-fn"}Therapeutic drugs\
systemic corticosteroids\
prednisone\
methylprednisolone\
antimalarials\
hydroxychloroquine\
immunosuppressive agents\
methotrexate\
cyclophosphamide\
tacrolimus\
mycophenolate mofetil\
azathioprine\
antifibrotic drugs\
pirfenidone\
Condition of patients during COVID-19\
improve\
worse\
unchanged\
Medical visit approach\
go to hospital\
telemedicine\
none\
26\
8\
\
17\
17\
\
24\
4\
\
33\
1\
\
\
13\
19\
\
16\
\
2\
9\
9\
2\
2\
\
1\
\
26\
4\
4\
\
22\
0\
12[^1]

Due to the pandemic of COVID-19, DM patients have difficulty obtaining a continuous, safe and effective therapy especially those who live in the countryside. Telemedicine is a convenient and safe option for patients and doctors[@bb0035] . It is necessary for doctors to contact their patients more closely and keep a watchful eye on patient\'s condition and provide medical guidance and psychological counseling form them. It is not necessary for patients to go to the hospital for routine referral at the risk of infection when their condition is stable and telemedicine maybe is a better choice. The self-monitoring of patient is also significant, they should pay more attention to the following points: (i) daily monitoring of body temperature; (ii) regular monitoring of blood pressure, blood sugar;(iii) observe side effects;(iv) maintain social distance; (v) accomplish room ventilation and disinfection.

Telemedicine can\'t solve all problems especially when the condition of patients get worse and is life-threatening. Therefore, guiding DM patients whether and when to come to the hospital for therapy needs to be taken seriously. we recommend that patients should come to hospital for therapy when the following manifestations occurs: (i) cutaneous manifestations (Gottron\'s papules, Gottron\'s sign, and heliotrope rash) become worse; myasthenia increased or presented as dysphagia, dysphonia and dyspnea; aggravated arthralgia.(ii) serious medication side effects developed.(iii) High fever and severe infection.

Discussion {#s0010}
==========

Telemedicine is a convenient method for the communication between doctors and patients. Many patients may be unaware of such an option for medical help. It is necessary to expand the use of telemedicine to reduce the risk of infection and prevent the spread of COVID-19. For severe patients, telemedicine is not a good choice because it has limitations in the diagnosis and treatment of serious diseases. The severe patients with unstable condition need timely and effective treatment provided by hospital.

Conclusion {#s0015}
==========

In the process of prevention and control of COVID-19, dermatomyositis patients as a group that needs special attention. The management of patients is a meaningful and challenging thing during the outbreak of COVID-19.
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[^1]: most drugs were used in combination.
